Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeMarket Insights Snapshot
In October 2026, Kind Medicine concentrated 83.60% of sales in Tincture & Sublingual, where category sales rose 12.61% year over year and 11.80% month over month, while the brand’s overall sales fell 13.98% YoY and average price rose 3.62%. Capsules shrank to 9.72% share with a 68.79% YoY decline and a 27.99% MoM drop, and Topical held 6.68% share with a 38.52% YoY decline and a 57.74% MoM contraction. With Tincture & Sublingual ranked 19th in California and commanding the mix, the pattern implies Kind Medicine is consolidating around one category while retreating from Capsules and Topical, trading breadth for depth.
The surge in Tincture & Sublingual alongside steep declines in Capsules and Topical indicates a deliberate pivot toward higher-velocity formats at a mid-tier price point ($34.24 average in Tincture & Sublingual vs. $50.67 in Capsules), suggesting price-sensitive demand capture and a repositioning away from premium encapsulated offerings. Given 24‑month sales down 2.56% and the October rank of 19 in Tincture & Sublingual in California, the mix shift implies Kind Medicine is aiming for sustained shelf presence through category focus rather than multi-category expansion, accepting lower category diversification to stabilize velocity and defend rank.
Competitive Landscape
Kind Medicine sits at rank 19 in California Tincture & Sublingual for October 2026, unchanged year over year at 19 while slipping 1 place from July 2026’s rank 18; against its historical context, the brand is 3 spots below its peak rank 16 from April 2025 and thus 19% farther from the top-10 threshold than at that peak. Competitive momentum is moving around it: Papa & Barkley holds rank 1 with an 8.27% year-over-year sales increase, while Yummi Karma is at rank 2 with a 20.79% year-over-year sales increase, and Mary's Medicinals climbed from rank 7 to rank 4 on 58.13% year-over-year growth. In contrast, Care By Design fell from rank 3 to rank 5 alongside a 35.91% year-over-year sales decline, and VET CBD improved from rank 4 to rank 3 despite a 4.35% year-over-year sales contraction, signaling that flat rank at 19 amid upward and downward shifts nearby implies Kind Medicine’s share is being diluted by faster-moving leaders and volatility above it rather than by direct head-to-head displacement in the teens.
Notable Products
Kind Medicine is concentrated in tinctures, with Tincture accounting for 83.6% of October 2026 sales and the top 10 items covering 99.3% of the lineup’s revenue. Indica Tincture (800mg THC,30ml) alone holds 25.1%, so most of its sales ride on a few tincture SKUs.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.






